DXST Decent Holding Inc. Annual reports only
Sanitary Services · Nasdaq · SEC CIK 1958133
Financial factors as of 2025-10-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY12.2%
TTM net income YoY-115.3%
TTM EPS YoY-114.3%
Revenue 3-yr CAGR53.3%
Net income 3-yr CAGR—
Margins
Gross margin26.2%
Operating margin-1.1%
Net margin-2.5%
FCF margin-26.7%
EBITDA margin-0.5%
Returns
ROE-5.1%
ROA-2.3%
ROIC (approx.)-1.9%
Asset turnover0.91x
Leverage & solvency
Liabilities / assets55.0%
Debt / equity0.00x
Current ratio1.71x
Interest coverage—
Cash quality & payout
Operating cash flow / net income10.72x
Accruals ratio22.1%
Payout ratio—
Capex / revenue0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-10-31 | FY20242024-10-31 | FY20232023-10-31 | FY20222022-10-31 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $12.95M | $11.54M | $9.45M | $3.59M |
| Cost of revenue | $9.56M | $8.33M | $6.23M | $1.94M |
| Gross profit | $3.39M | $3.21M | $3.22M | $1.65M |
| R&D expense | $302,118 | $28,981 | $122,441 | $60,883 |
| SG&A expense | $2.78M | $662,158 | $851,130 | $1.06M |
| Operating income | -$138,576 | $2.47M | $2.17M | $498,522 |
| Interest expense | $0 | $0 | $6,017 | $86,671 |
| Pretax income | -$119,302 | $2.48M | $2.18M | $431,449 |
| Income tax | $202,900 | $380,767 | $316,927 | $59,014 |
| Net income | -$322,202 | $2.10M | $1.86M | $372,435 |
| EBITDA | -$68,079 | $2.55M | $2.22M | $518,049 |
| EPS (basic) | -0.02 | 0.14 | 0.12 | 0.02 |
| EPS (diluted) | -0.02 | 0.14 | 0.12 | 0.02 |
| Weighted avg. shares (diluted) | 16.25M | 15.00M | 15.00M | 15.00M |
| Balance sheet | ||||
| Cash & equivalents | $572,807 | $407,031 | $1.33M | $1.97M |
| Receivables | $12.38M | $8.70M | $2.18M | — |
| Inventory | $128 | $134 | $187 | — |
| Current assets | $16.09M | $9.77M | $4.20M | — |
| PP&E, net | $201,539 | $242,185 | $266,987 | — |
| Intangibles | $5,738 | $6,088 | $6,264 | — |
| Total assets | $17.18M | $11.24M | $5.34M | — |
| Current liabilities | $9.40M | $6.21M | $2.49M | — |
| Total liabilities | $9.45M | $6.22M | $2.53M | — |
| Shareholders' equity | $7.73M | $5.02M | $2.81M | $1.02M |
| Shares outstanding | — | 15.00M | 15.00M | — |
| Cash flow statement | ||||
| Operating cash flow | -$3.46M | -$362,322 | $1.58M | $1.39M |
| Capital expenditure | $589 | $78,133 | $153,794 | $241,211 |
| Free cash flow | -$3.46M | -$440,455 | $1.43M | $1.15M |
| Investing cash flow | -$321,903 | -$117,481 | -$143,035 | $599,614 |
| Financing cash flow | $3.94M | -$466,614 | -$2.10M | -$544,355 |
| Depreciation & amortization | $70,497 | $76,594 | $45,455 | $19,527 |
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.